Finally, the first positive trial of immunotherapy in the definitive Rx of mucosal LA # HNCA; look forward to more practice changing IO studies thelancet.com/journals/lance… thelancet.com/journals/lance…

In an episode of the Backtable ENT (BackTable ENT) podcast, Winship otolaryngologist Nikki Schmitt, MD, FACS discusses drug repurposing for head and neck cancer. ➡️Listen here: brnw.ch/21wKK8H

New Post! Thank you to Dr. Michael Baddour, Head & Neck Surgeon at Emory University, who composed this expert review of the importance of understanding perineural spread in cutaneous squamous cell carcinomas of the head and neck. #AHNSSkin AHNS ow.ly/1c9150SzPYB

😇 Excited for the Pittsburgh Annual Oncology Symposium this week! ✨ Join us for updates on cutting edge cancer research, and network with exceptional speakers & leaders in the field ✨✨ UPMC Physician Resources UPMC Hillman Cancer Center John Rhee Ibrahim Halil SAHIN, MD Dennis Hsu Janie Y. Zhang, MD

Great to host ⁦Ravi Uppaluri, MDPhD at the Winship Cancer Institute of Emory University⁩ Elkin lecture series; great talk and discussions around future IO applications in the peri OP #HNCA setting; ⁦Gregory Lesinski⁩ ⁦Chrystal Paulos⁩ ⁦Schmitt Lab⁩

🎉Congrats to Winship researcher Canhua Xiao, PhD, RN, FAAN, on being awarded a $3.3M grant from National Cancer Institute to study the psychosocial impacts of immunotherapy for advanced head and neck cancer patients.➡️Learn more: brnw.ch/21wN3ky

Ravi Uppaluri, MDPhD Robert Haddad Glenn J. Hanna, M.D. R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) Robert Ferris, MD, PhD Schmitt Lab Jonathan Schoenfeld Dr. Gavin P. Dunn Toni Choueiri, MD Kartik Sehgal Very glad #HNCA is finally getting on the wagon of pre op IO; this is long time coming and great news for our patients; Winship Cancer Institute of Emory University ASCO AHNS

Sharing our recently published encouraging long term outcomes of Pembrolizumab and Cabozantinib in #RMHNSCC Winship Cancer Institute of Emory University Moffitt Cancer Center aacrjournals.org/clincancerres/…

We’ve issued new guidelines on the use of transoral robotic surgery in the treatment of oropharyngeal #SquamousCellCarcinoma: brnw.ch/21wQD6p Co-authored by @hnsurgeon, @patelMDDDS, hstarmer, @DRNabilSaba, @vinpaleri #OPSCC #hncsm #oralcancer

INO-3107 DNA immunoRx induction of CD8+ HPV 6 & 11 T cell trafficking in #RRP another proof of principle in another #HPV related disease ⁦INOVIO Pharmaceuticals⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦Univ Cincinnati⁩ ⁦Johns Hopkins University⁩ Source: Nature search.app/jbQ57jJPzP66WF…

In eBioMedicine – The Lancet Discovery Science we present SMuRF, a Swin Transformer-based model for fusing CT & HE slides to predict survival & tumor grade in HPV-associated OPSCC. 🔹 81% accuracy in survival prediction 🔹 Outperforms single-modality models (AUC = 0.75)📖 Read more at tinyurl.com/35ch4kn7

🚨 New pub alert in Eur J of Cancer🚨 We introduce VISTA, an AI-virtual staining tool transforming H&E to IHC to detect M2-TAMs in HPV+ oropharyngeal cancer. 🔬 High M2-TAM density = worse survival (p=0.0152, HR=1.63) 🧠 VISTA >existing methods 📄 Paper: tinyurl.com/7sb65m7u

EA3231 is a phase 3 #ClinicalTrial of targeted therapy vs. chemotherapy in patients with differentiated #ThyroidCancer (DTC) with a BRAF V600E mutation. Learn more during #HeadandNeckCancerAwareness Month: bit.ly/ea3231-study cc: Lova Sun, Nabil Saba, MD, Laila Gharzai MD LLM

Planning your day for ASCO? Join Dan Zandberg for an oral presentation on cSCC. #ASCO25 UPMC Physician Resources UPMC

Great #ASCO25 discussion by ⁦Anant Madabhushi⁩ around AI based prediction models in #HNCA ⁦Winship Cancer Institute of Emory University⁩ ⁦Emory University⁩ ⁦ASCO⁩ ⁦MedAI Emory⁩

Excellent presentation by ⁦Conor Steuer⁩ covering reversal of immunosuppressive environment with #pepinemab in #HNCA ASCO CSS ⁦Winship Cancer Institute of Emory University⁩ ⁦Emory University⁩ ⁦Gregory Lesinski⁩ Vaccinex⁩ ⁦Schmitt Lab⁩

Kudos Nabil Saba, MD! Winship Cancer Institute of Emory University Emory School of Medicine

Excited to share our study of RT + IAP antagonist tolinapant in cis-ineligible HNSCC, showing safety/feasibility and promising LRC …rjournals-org.proxy.library.emory.edu/clincancerres/… Bill Stokes Nabil Saba, MD James Bates

“The results support chemotherapy before surgery as an effective intervention to improve preservation of vital organs, bone, and tissue in patients w nose/sinus cancer” Nabil Saba, MD Winship Cancer Institute of Emory University who led ECOG-ACRIN EA3163 w Barbara Burtness Yale Cancer Center et al Clinical Cancer Research #hncsm

Join us in Atlanta on Sept 6th for Updates in the Management of Head and Neck Cancer Symposium featuring known experts ⁦Winship Cancer Institute of Emory University⁩ ⁦Dan Zandberg⁩ Renata Ferrarotto ⁦Schmitt Lab⁩ ⁦Conor Steuer⁩ ⁦⁦Bill Stokes⁩ cmetracker.net/EMORY/Publishe…